Intelligent Bio Solutions Inc. to Present First Quarter 2023 Financial Results and Recent Corporate Update on November 9
02. November 2022 16:05 ET
|
Intelligent Bio Solutions, Inc.
NEW YORK, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (the “Company”), a life sciences company delivering intelligent, non-invasive, real-time testing solutions,...
GBS Inc. Reports Third Quarter 2022 Financial Results and Recent Business Highlights
10. Mai 2022 16:05 ET
|
GBS Inc.
- Initiated prospective study to collect coincident samples of oral fluid and blood following IRB approval - - Finalizing site selection at the University of Newcastle campus for the high-tech...
GBS Inc. Reports Second Quarter 2022 Financial Results and Recent Business Highlights
10. Februar 2022 16:05 ET
|
GBS Inc.
- Discussions underway between the University of Newcastle and GBS to oversee the high-tech manufacturing facility supported by its $4.7 Million Grant Funding Award from Australian Government - -...
GBS Inc. Reports First Quarter 2022 Financial Results and Recent Business Highlights
11. November 2021 16:05 ET
|
GBS Inc.
– Announced Pre-Submission Package sent to the FDA for its Glucose Biosensor Test – – Clinical Validation Study Results for SARS CoV2 Ab Test – – Evaluating site locations for build out of...
GBS Inc. to Present First Quarter 2022 Financial Results and Recent Corporate Update on November 11
01. November 2021 16:05 ET
|
GBS Inc.
NEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners...
GBS Inc. Announces Executive Leadership Changes to Accelerate Product Development and Manufacturing
01. November 2021 08:00 ET
|
GBS Inc.
NEW YORK, Nov. 01, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners...
GBS Inc. Announces its Pre-Submission package is with the FDA
13. Oktober 2021 08:30 ET
|
GBS Inc.
NEW YORK, Oct. 13, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at...
GBS Inc. to Present at Upcoming September Virtual Investor Conferences
07. September 2021 16:05 ET
|
GBS Inc.
H.C. Wainwright 23rd Global Investor Conference: September 13th - 15th Benzinga Healthcare Small Cap Conference: September 29th - 30th NEW YORK, Sept. 07, 2021 (GLOBE NEWSWIRE) -- GBS (Nasdaq:...
GBS Inc. Reports Fourth Quarter and Full Year 2021 Preliminary Financial Results and Recent Business Highlights
11. August 2021 16:05 ET
|
GBS Inc.
- Awarded $4.7 Million Government Grant Funding to support the building of a high-tech manufacturing facility - - Signs Strategic Partnerships with Johns Hopkins University, Wyss Institute from...
GBS Inc. to Present Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Update on August 11
29. Juli 2021 08:30 ET
|
GBS Inc.
NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- GBS Inc. (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners...